Literature DB >> 956344

Reversal of decreased human adipose tissue lipoprotein lipase and hypertriglyceridemia after treatment of hypothyroidism.

O Pykälistö, A P Goldberg, J D Brunzell.   

Abstract

To determine whether adipose tissue lipoprotein lipase (LPL) plays a role in the regulation of triglyceride (TG) metabolism in hypothyroidism, the activity of the enzyme was measured in the subcutaneous adipose tissue of six hypothyroid patients before and during therapy with L-thyroxine. The activity of the activated form of the enzyme, measured as heparin elutable LPL, was lower in hypothyroid patients (1.54 +/- 0.93; mU/10(6) cells; mean +/- SD) than in controls (3.26 +/- 1.49; P less than .02) and increased (163 +/- 89%; P less than .01) with treatment to levels comparable to the controls. The total activity of LPL, measured in ammonium hydroxide extracts of acetone ether tissue powders, was in the low normal range in the hypothyroid patients (0.68 +/- 0.42), but not significantly different from normal (1.10 +/- 0.58) and did not increase significantly (92 +/- 105%), with treatment. Plasma post heparin lipolytic activity (PHLA) was low in hypothyroidism and increased (111 +/- 78%; P less than .05) with treatment. These increases in PHLA correlated with the increases in the activity of heparin elutable LPL (r = .88, P less than .05). In all patients fasting plasma TG levels decreased (-43 +/- 25%; P less than .02) after treatment. Serial determination of heparin elutable LPL activity, PHLA, and plasma TG during L-thyroxine treatment revealed a correlation between the per cent changes in PHLA and heparin elutable LPL activity (r = .68, P less than .05), an inverse correlation between plasma TG levels and heparin elutable LPL (r = -0.53,P less than .05) and no correlation between plasma TG and PHLA (r = -0.05). These results suggest that the low PHLA and hypertriglyceridemia of hypothyroidism are related to low adipose tissue LPL activity. All these parameters return to normal after treatment with L-thyroxine and attainment of euthyroidism.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 956344     DOI: 10.1210/jcem-43-3-591

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Lipid effects of endocrine medications.

Authors:  Dan V Mihailescu; Avni Vora; Theodore Mazzone
Journal:  Curr Atheroscler Rep       Date:  2011-02       Impact factor: 5.113

2.  Lipid transport in the hypothyroid rat as reflected by the serum concentrations of free fatty acids, lipoproteins, lecithin-cholesterol acyltransferase and lipoprotein lipase activity in adipose tissue.

Authors:  U Rosenqvist; R Mahler; L A Carlson
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

3.  Effects of thyroidectomy and starvation on the activity and properties of hepatic carnitine palmitoyltransferase.

Authors:  E D Saggerson; C A Carpenter; B S Tselentis
Journal:  Biochem J       Date:  1982-12-15       Impact factor: 3.857

4.  Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase.

Authors:  D M Applebaum; A P Goldberg; O J Pykälistö; J D Brunzell; W R Hazzard
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

5.  Regulation of lipoprotein lipase in primary cultures of isolated human adipocytes.

Authors:  P A Kern; S Marshall; R H Eckel
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

6.  Persistent pituitary resistance to thyroid hormone in congenital versus later-onset hypothyroidism.

Authors:  H Cavaliere; G A Medeiros-Neto; W Rosner; I A Kourides
Journal:  J Endocrinol Invest       Date:  1985-12       Impact factor: 4.256

Review 7.  Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia.

Authors:  Eszter Berta; Noémi Zsíros; Miklós Bodor; István Balogh; Hajnalka Lőrincz; György Paragh; Mariann Harangi
Journal:  Genes (Basel)       Date:  2022-06-27       Impact factor: 4.141

Review 8.  Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk.

Authors:  Bryant H Keirns; Christina M Sciarrillo; Nicholas A Koemel; Sam R Emerson
Journal:  J Nutr Sci       Date:  2021-09-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.